[go: up one dir, main page]

HK40093610A - Lzk-targeting degraders and methods of use - Google Patents

Lzk-targeting degraders and methods of use Download PDF

Info

Publication number
HK40093610A
HK40093610A HK62023082317.6A HK62023082317A HK40093610A HK 40093610 A HK40093610 A HK 40093610A HK 62023082317 A HK62023082317 A HK 62023082317A HK 40093610 A HK40093610 A HK 40093610A
Authority
HK
Hong Kong
Prior art keywords
lzk
degraders
targeting
methods
targeting degraders
Prior art date
Application number
HK62023082317.6A
Other languages
Chinese (zh)
Inventor
John F. BROGNARD
Rolf E. Swenson
Amy L. FUNK
Carolyn W. HITKO
Katherine M. NYSWANER
Eric Lindberg
Venkatareddy SABBASANI
Knickole L. BERGMAN
Original Assignee
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The United States Of America, As Represented By The Secretary, Department Of Health And Human Services filed Critical The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
Publication of HK40093610A publication Critical patent/HK40093610A/en

Links

HK62023082317.6A 2020-09-02 2021-09-01 Lzk-targeting degraders and methods of use HK40093610A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/073,835 2020-09-02

Publications (1)

Publication Number Publication Date
HK40093610A true HK40093610A (en) 2024-01-05

Family

ID=

Similar Documents

Publication Publication Date Title
EP4143196A4 (en) PI3K-a INHIBITORS AND METHODS OF USE THEREOF
EP4161519A4 (en) Purines and methods of their use
EP4341254A4 (en) Inhibitors and degraders of pip4k protein
EP4355229A4 (en) Hemostasis devices and methods of use
EP4175943A4 (en) Dual-functional compounds and methods of use
CA3262145A1 (en) Aza-quinazoline compounds and methods of use
EP4017493A4 (en) Methods of treatment using bcn057 and bcn512
CA3248844A1 (en) Anti-b7-h3 compounds and methods of use
EP4329735A4 (en) Kcnt1 inhibitors and methods of use
EP4146196A4 (en) Akt3 modulators and methods of use thereof
HK40093610A (en) Lzk-targeting degraders and methods of use
HK40087353A (en) Tie2-binding agents and methods of use
CA3269745A1 (en) Nek7 degraders and methods of use thereof
HK40093465A (en) Lair-1-binding agents and methods of use thereof
HK40081711A (en) Ilt-binding agents and methods of use thereof
HK40101141A (en) Gpr52 modulators and methods of use
TWI908931B (en) Compounds and methods of use thereof
HK40086352A (en) Compounds and methods of use
HK40082392A (en) Gpr52 modulators and methods of use
HK40089940A (en) MODULATORS OF THR-β AND METHODS OF USE THEREOF
HK40094160A (en) Auto-injector and related methods of use
HK40113303A (en) Positive nmda-modulating compounds and methods of use thereof
HK40116199A (en) Enhanced expression system and methods of use thereof
HK40088893A (en) Meayamycin analogues and methods of use
HK40103407A (en) Urolithin derivatives and methods of use thereof